The Schwab US Dividend Equity ETF (SCHD) invests in mature, profitable companies with a blended price-to-earnings ratio of 15.6x, significantly cheaper than the S&P 500's 32x. It offers defensive exposure with 35% in healthcare and consumer staples, sectors that tend to hold up well during market downturns and are currently undervalued. While SCHD may lag in tech-driven rallies, it has historically outperformed the S&P 500 during periods of valuation resets and growth concerns. The author allocates 10-30% of new capital to SCHD for diversification, attractive yield, and psychological comfort during volatile markets.
The S&P 500 remains resilient, just 3.5% below its all-time highs, showing a solid 10% gain year-to-date despite recent volatility driven by tech sector cash flow concerns. Q3 earnings per share growth is robust at 30%, and market breadth is improvin...
The Schwab US Dividend Equity ETF (SCHD) is recommended as a Buy for the next 12 to 24 months due to consistent dividend growth and robust portfolio diversification. Its healthcare sector allocation has increased to nearly 19%, making it a key driver...
The Schwab US Dividend Equity ETF (SCHD) is recommended as a strong buy due to its focus on high-quality dividends, lower exposure to volatile technology sectors, and stable cash flows. This makes it a defensive choice for retirees and cautious incom...
The article outlines a diversified dividend portfolio combining ETFs, funds, and high-yield stocks to achieve a 5.59% average dividend yield and a 6.16% annual dividend growth over five years. Key holdings include Schwab U.S. Dividend Equity ETF, Mic...
